Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 10, 2021	SC 13G/A	An amendment to the SC 13G filing	0000093751-21-000186.pdf 0000093751-21-000186.rtf View HTML
February 12, 2021	SC 13G/A	An amendment to the SC 13G filing	0001104659-21-021132.pdf 0001104659-21-021132.rtf 0001104659-21-021132.xls View HTML
July 12, 2021	SC 13G/A	An amendment to the SC 13G filing	0000093751-21-000625.pdf 0000093751-21-000625.rtf View HTML
August 10, 2021	SC 13G/A	An amendment to the SC 13G filing	0000902219-21-000380.pdf 0000902219-21-000380.rtf 0000902219-21-000380.xls View HTML
February 7, 2022	SC 13G/A	An amendment to the SC 13G filing	0000834237-22-007946.pdf 0000834237-22-007946.rtf View HTML
February 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0001104659-22-016399.pdf 0001104659-22-016399.rtf View HTML
February 10, 2022	SC 13G/A	An amendment to the SC 13G filing	0000093751-22-000122.pdf 0000093751-22-000122.rtf View HTML
June 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0001104659-22-069630.pdf 0001104659-22-069630.rtf View HTML
January 20, 2023	SC 13G/A	An amendment to the SC 13G filing	0000093751-23-000018.pdf 0000093751-23-000018.rtf View HTML
February 9, 2023	SC 13G/A	An amendment to the SC 13G filing	0001104659-23-015229.pdf 0001104659-23-015229.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax